Champions Oncology Inc. (CSBR) Financial Ratios & Valuation Metrics Analysis - P/E, ROE, Debt Ratios & Profitability - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Champions Oncology Inc.

    NASDAQ: CSBR · Real-Time Price · USD
    6.45
    0.06 (0.94%)
    At close: Oct 03, 2025, 3:59 PM
    6.39
    -0.93%
    After-hours: Oct 03, 2025, 04:10 PM EDT

    Champions Oncology Ratios and Metrics

    Financials in USD. Fiscal year is May - April.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Apr 30, 2025 Apr 30, 2024 Apr 30, 2023 Apr 30, 2022 Apr 30, 2021
    PE Ratio
    		 20.78 -9.03 -12.34 184.95 389.45
    PEG Ratio
    		 -0.13 -0.23 0.01 3.67 -3.35
    PS Ratio
    		 1.72 1.31 1.22 2.06 3.44
    PB Ratio
    		 25.89 -34.53 14.20 11.14 18.98
    P/FCF Ratio
    		 13.96 -9.42 60.77 24.64 -28.41
    P/OCF Ratio
    		 13.22 -10.71 16.64 15.60 -83.87
    OCF/S Ratio
    		 0.13 -0.12 0.07 0.13 -0.04
    Debt / Equity Ratio
    		 1.62 -3.9 1.85 1.04 1.29
    Quick Ratio
    		 0.94 0.63 0.90 1.13 1.13
    Current Ratio
    		 0.94 0.63 0.90 1.13 1.13
    Asset Turnover
    		 1.76 1.92 1.57 1.39 1.49
    Interest Coverage
    		 168.63 n/a n/a 25.29 n/a
    Return on Equity
    		 1.25 3.82 -1.15 0.06 0.05
    Return on Assets
    		 0.15 -0.28 -0.16 0.02 0.01
    Return on Invested Capital
    		 0.46 -1.24 -0.3 0.03 0.02
    Dividend Yield
    		 n/a n/a n/a n/a n/a
    Payout Ratio
    		 n/a n/a n/a n/a n/a
    Gross Profit Margin
    		 0.50 0.41 0.45 0.52 0.48
    Net Profit Margin
    		 0.08 -0.15 -0.1 0.01 0.01
    Pretax Profit Margin
    		 0.08 -0.15 -0.1 0.01 0.01
    Operating Profit Margin
    		 0.08 -0.15 -0.08 0.01 0.01
    FCF Margin
    		 0.12 -0.14 0.02 0.08 -0.12
    EBITDA Margin
    		 0.11 -0.1 -0.04 0.05 0.01

    Add to Watchlist